Skip to main content
AAO-HNSF 2026 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Panel Presentation

Pediatric Otolaryngology

Tranexamic Acid for Post-tonsillectomy Hemorrhage: Evidence, Algorithms, and Real-world Implementation

Tuesday, October 20, 2026
11:15 AM - 12:15 PM PT
Location: 409AB
Disclosure(s):
Jason S. Park, MD, PhD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

This interactive panel will review the pharmacology & safety profile of TXA, synthesizing the emerging literature supporting its use in PTH. Panelists will present institutional algorithms & real-world outcomes - highlighting successes, failures, & implementation barriers. Through case-based discussion, participants will explore practical decision-making strategies & identify opportunities to standardize care while maintaining patient safety. The session will include a point–counterpoint discussion on prophylactic vs. reactive TXA use with audience polling to assess current practice patterns. This session is designed for general, pediatric, & comprehensive otolaryngologists seeking evidence-based, immediately applicable guidance for managing PTH in contemporary practice.

Learning Objectives:

  • Describe the mechanism of action, safety profile, and contraindications of acid relevant to otolaryngologic practice and compare evidence supporting prophylactic versus reactive use of TXA in pediatric and adult tonsillectomy patients.
  • Apply TXA-based management strategies to clinical scenarios involving active post-tonsillectomy hemorrhage and high-risk patients without bleeding.
  • Critically evaluate institutional algorithms that incorporate TXA as a preventive or rescue therapy and identify barriers to implementation & formulate an evidence-informed approach to TXA utilization that balances patient safety, resource utilization, and institutional feasibility.